Funding for this research was provided by:
Medizinische Universität Wien
Text and Data Mining valid from 2018-05-18
Received: 6 February 2018
Accepted: 27 April 2018
First Online: 18 May 2018
Conflict of interest
: R. Pirker has received speaker’s fees and/or honoraria for consulting from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Genmab, MSD and Roche. A. Tiefenbacher declares that he has no competing interests.